<?xml version="1.0" encoding="iso-8859-1" standalone="no"?>
<!DOCTYPE GmsArticle SYSTEM "http://www.egms.de/dtd/2.0.34/GmsArticle.dtd">
<GmsArticle xmlns:xlink="http://www.w3.org/1999/xlink">
  <MetaData>
    <Identifier>25premus129</Identifier>
    <IdentifierDoi>10.3205/25premus129</IdentifierDoi>
    <IdentifierUrn>urn:nbn:de:0183-25premus1293</IdentifierUrn>
    <ArticleType>Meeting Abstract</ArticleType>
    <TitleGroup>
      <Title language="en">Development of a mobile health app for active monitoring of work-related musculoskeletal complaints</Title>
    </TitleGroup>
    <CreatorList>
      <Creator>
        <PersonNames>
          <Lastname>Roger</Lastname>
          <LastnameHeading>Roger</LastnameHeading>
          <Firstname>Nathan</Firstname>
          <Initials>N</Initials>
        </PersonNames>
        <Address>
          <Affiliation>UR-UPJV EA 3300, APERE - Adaptations Physiologiques &#225; l&#39;Exercice et R&#233;adaptation &#225; l&#39;effort - UFR des Sciences du Sport, Universit&#233; de Picardie Jules Verne, Amiens, France</Affiliation>
          <Affiliation>Laboratoire P&#233;riTox UMR-I 01, Centre Universitaire de Recherche en Sant&#233;, Universit&#233; de Picardie Jules Verne, Amiens, France</Affiliation>
          <Affiliation>Groupe Bigard, Flixecourt, France</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Delignieres</Lastname>
          <LastnameHeading>Delignieres</LastnameHeading>
          <Firstname>Pierre</Firstname>
          <Initials>P</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Groupe Bigard, Flixecourt, France</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Lelard</Lastname>
          <LastnameHeading>Lelard</LastnameHeading>
          <Firstname>Thierry</Firstname>
          <Initials>T</Initials>
        </PersonNames>
        <Address>
          <Affiliation>UR-UPJV EA 3300, APERE - Adaptations Physiologiques &#225; l&#39;Exercice et R&#233;adaptation &#225; l&#39;effort - UFR des Sciences du Sport, Universit&#233; de Picardie Jules Verne, Amiens, France</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Telliez</Lastname>
          <LastnameHeading>Telliez</LastnameHeading>
          <Firstname>Frederic</Firstname>
          <Initials>F</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Laboratoire P&#233;riTox UMR-I 01, Centre Universitaire de Recherche en Sant&#233;, Universit&#233; de Picardie Jules Verne, Amiens, France</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
    </CreatorList>
    <PublisherList>
      <Publisher>
        <Corporation>
          <Corporatename>German Medical Science GMS Publishing House</Corporatename>
        </Corporation>
        <Address>D&#252;sseldorf</Address>
      </Publisher>
    </PublisherList>
    <SubjectGroup>
      <SubjectheadingDDB>610</SubjectheadingDDB>
    </SubjectGroup>
    <DatePublishedList>
      <DatePublished>20250909</DatePublished>
    </DatePublishedList>
    <Language>engl</Language>
    <License license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
      <AltText language="en">This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License.</AltText>
      <AltText language="de">Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung).</AltText>
    </License>
    <SourceGroup>
      <Meeting>
        <MeetingId>M0625</MeetingId>
        <MeetingSequence>129</MeetingSequence>
        <MeetingName>12th International Scientific Conference on the Prevention of Work-Related Musculoskeletal Disorders</MeetingName>
        <MeetingTitle>PREMUS 2025</MeetingTitle>
        <MeetingSession>Poster PO 3</MeetingSession>
        <MeetingCity>T&#252;bingen</MeetingCity>
        <MeetingDate>
          <DateFrom>20250909</DateFrom>
          <DateTo>20250912</DateTo>
        </MeetingDate>
      </Meeting>
    </SourceGroup>
    <ArticleNo>129</ArticleNo>
  </MetaData>
  <OrigData>
    <TextBlock name="Text" linked="yes">
      <MainHeadline>Text</MainHeadline><Pgraph><Mark1>Introduction:</Mark1> Musculoskeletal Disorders (MSDs) are a major cause of occupational health issues. Implementing an effective MSD prevention strategy in the workplace requires the characterization and monitoring of workers&#8217; musculoskeletal health based on reliable and reproducible indicators. The objective of this study was to develop an innovative mobile application designed to map musculoskeletal complaints and to test its implementation in an industrial site specialized in meat packaging. </Pgraph><Pgraph><Mark1>Methods:</Mark1> The application development process followed several key steps: </Pgraph><Pgraph><OrderedList><ListItem level="1" levelPosition="1" numString="1.">Formation of a multidisciplinary working group (site director, HR manager, occupational physician, university researchers specialized in locomotion and applied work physiology, employee representatives, and a software developer) under the coordination of a doctoral student embedded in the company. </ListItem><ListItem level="1" levelPosition="2" numString="2.">Selection of the Nordic Musculoskeletal Questionnaire as a scientifically validated monitoring tool. </ListItem><ListItem level="1" levelPosition="3" numString="3.">Integration of modules designed to characterize individual worker characteristics and work conditions. </ListItem><ListItem level="1" levelPosition="4" numString="4.">Development of the application on a company-owned internal server, ensuring data anonymization and compliance with data protection regulations (CNIL, GDPR). </ListItem><ListItem level="1" levelPosition="5" numString="5.">Presentation and refinement of the tool through feedback from the working group. </ListItem><ListItem level="1" levelPosition="6" numString="6.">Testing on 235 employees using a combined approach (individual interviews &#43; data entry via tablet). </ListItem><ListItem level="1" levelPosition="7" numString="7.">Data analysis and result dissemination.</ListItem></OrderedList></Pgraph><Pgraph><Mark1>Results:</Mark1> The tool was tested over a six-month period. Out of 300 employees at the site, 235 participated in the study and completed the questionnaire via the mobile application during an individual interview lasting 10 to 20 minutes. Among these participants, 86&#37; reported at least one musculoskeletal pain episode in the past 12 months. The three most affected body regions were: Lower back (56&#37; of participants); Shoulders (33&#37;) and Neck (21&#37;). Among the 13 company sectors, the most impacted were: &#8220;Processed products&#8221;, &#8220;Labeling&#8221;, and &#8220;Forming&#8221;.</Pgraph><Pgraph><Mark1>Discussion:</Mark1> The developed tool enabled the mapping of musculoskeletal complaints for 78&#37; of the workforce and identified three priority sectors for preventive actions: </Pgraph><Pgraph><OrderedList><ListItem level="1" levelPosition="1" numString="1.">Training: implementation of an on-the-job training approach (AFEST in French). </ListItem><ListItem level="1" levelPosition="2" numString="2.">Organizational measures: promotion of job rotation, workforce increase, and implementation of workplace warm-up exercises. </ListItem><ListItem level="1" levelPosition="3" numString="3.">Technical measures: provision of adapted equipment and automation of certain tasks.</ListItem></OrderedList></Pgraph><Pgraph><Mark1>Conclusion:</Mark1> Using a mobile application to map musculoskeletal pain, combined with individual interviews, represents a promising approach to improving MSD prevention in the workplace. This tool has facilitated the establishment of a structured and actionable prevention indicator shared by both employees and management. Since 2024, the tool has been deployed every three months to assess the impact of preventive actions in other sectors. In the long term, it will support data modeling to refine etiopathogenic models of MSDs.</Pgraph><Pgraph>&#91;1&#93; Kuorinka et al., 1987.</Pgraph></TextBlock>
    <Media>
      <Tables>
        <NoOfTables>0</NoOfTables>
      </Tables>
      <Figures>
        <NoOfPictures>0</NoOfPictures>
      </Figures>
      <InlineFigures>
        <NoOfPictures>0</NoOfPictures>
      </InlineFigures>
      <Attachments>
        <NoOfAttachments>0</NoOfAttachments>
      </Attachments>
    </Media>
  </OrigData>
</GmsArticle>